Skip to main content

Table 5 The impact of the ApoB rs676210 polymorphism on the lipid profile and oxLDL of the control group

From: ApoB gene polymorphism (rs676210) and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease

Parameters

Genotype (mean+SD)

G/G (n = 66)

G/A (n = 28)

A/A (n = 6)

P value

TC (mg/dl)

140.52±20.01

136.83±26.26

134.02±15.43

0.63

TG (mg/dl)

111.63±17.11

113.47±20.62

115.08±12.49

0.84

HDL (mg/dl)

52.21±9.47

51.49±8.77

49.25±13.35

0.74

LDL (mg/dl)

65.98±19.79

62.65±23.39

61.75±24.49

0.73

VLDL (mg/dl)

22.32±3.42

22.69±4.12

23.01±2.49

0.84

OX-LDL (U/L)

50.20±8.77

43.39±9.66

38.58±12.90

0.42

  1. ANOVA significance test (2-tailed)